Ibuprofen May Help Stave Off Parkinson's

Finding suggests need to look closer at the disease as inflammatory, expert says

By Ellin Holohan
HealthDay Reporter

Related Encyclopedia • Acoustic Neurinoma • Bell's Palsy • Brain and Spinal Cord Magnetic Resonance Imaging • Brain Tumors More... Related Healthscout Videos Say Ahh! The First Oral Treatment for MS Coming Around: Coma Breakthroughs Saving Memories with a Shake: The Alzheimer's Drink Suffocating Damaged Nerves Back to Life More... Related Drug Information • Adderal XR • Concerta • Coumadin • Depakote More... Related News Articles • Brain Scans May Predict How People Learn • Gloves, Padded Headgear Helps Protect Boxers • Study Weighs Pros, Cons of Home or Hospital Birth • In Mice, Cancer Drug Shows Effect on Alzheimer's Symptoms More...

WEDNESDAY, Feb. 17 (HealthDay News) -- Regular use of ibuprofen, a common anti-inflammatory drug, significantly lowers the risk for developing Parkinson's disease, Harvard researchers report.

People who took three or more tablets a week showed a 40 percent lower risk than those who didn't take the common pain reliever, their study found.

Text Continues Below

---

Study author Dr. Xiang Gao, an instructor and epidemiologist at Harvard Medical School and Brigham and Women's Hospital in Boston, said the findings are important for anyone at increased risk for Parkinson's because most people with the disease eventually become severely disabled.

"There is thus a need for better preventive interventions," Gao said. "In this context, our findings regarding the potential neuroprotective effect of ibuprofen, one of the most commonly used analgesics, on Parkinson's disease may have important public health and clinical implications."

Parkinson's is a disease that affects nerve cells in the brain that control the movement of muscles. It affects an estimated 1 million people in the United States, men far more often than women. The exact cause is unknown, but experts believe it's a combination of genetic and environmental factors.

Gao said that though the drug levodopa is the current standard treatment for Parkinson's, much more is needed. He is scheduled to present the findings in Toronto at the annual meeting of the American Academy of Neurology in April.

The findings came from an analysis of data on 136,474 people who did not have Parkinson's at the start of the study. In a six-year span, 293 were diagnosed with the disease. Those who took the largest doses of ibuprofen were less likely to have developed Parkinson's than were those who took smaller amounts of the drug, the study found.

No other pain reliever was found to lower the risk for Parkinson's.

Dr. Michele Tagliati, an associate professor of neurology and director of the Parkinson's Disease Center at the Mount Sinai School of Medicine in New York City, described the results as somewhat surprising and said they emphasized the need for further study.

Page:  1 | 2 | Next >>